BackZevra Therapeutics Overview
Zevra Therapeutics Inc

Zevra Therapeutics Discounted Cash Flow

DCF Analysis for KMPH.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$34.03

Current Fair Value

$34.03
485.7% Upside

Undervalued by 485.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading